Skip to main content
SpringerLink
Log in

Obesity and Chronic Disease

  • Chapter
  • First Online:
Chronic Illness Care

  • 706 Accesses

Abstract

Obesity is a serious worldwide epidemic and is due to an interaction of human physiology and metabolism in the setting of complex environmental factors of reduced physical activity, the ready availability of food, and socioeconomic factors. Obesity is itself a disease and is a major contributor to other chronic diseases such as diabetes, hypertension, osteoarthritis, fatty liver disease, varicose veins, intertrigo, gastroesophageal reflux disorder, heart failure, pulmonary embolism, asthma, obstructive sleep apnea/obesity hypoventilation syndrome, idiopathic intracranial hypertension, and depression. Effective weight loss strategies must include lifestyle changes of dietary modifications and physical activities. If these approaches are not successful, treatment with pharmacotherapy or metabolic surgery can be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief, no 360. Hyattsville, MD: National Center for Health Statistics. 2020.

    Google Scholar 

  2. World Health Organization. Obesity and overweight [Internet]. [cited 2022 Sep 10]. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight

  3. Heymsfield SB, Wadden TA. Mechanisms, pathophysiology, and management of obesity. N Engl J Med. 2017;376(3):254–66.

    Article  CAS  PubMed  Google Scholar 

  4. Kushner RF, Ryan DH. Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews. JAMA. 2014;312(9):943–52.

    Article  CAS  PubMed  Google Scholar 

  5. CDC. Defining adult overweight and obesity [Internet]. Centers for Disease Control and Prevention; 2022 [cited 2022 Sep 5]. https://www.cdc.gov/obesity/basics/adult-defining.html

  6. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. National Institutes of Health. Obes Res. 1998;6(Suppl 2):51S–209S.

    Google Scholar 

  7. Obesity Expert Panel, National Heart, Lung, and Blood Institute. Guidelines (2013) for managing overweight and obesity in adults. Obesity (Silver Spring). 2014;22(Suppl 2):S40.

    Google Scholar 

  8. Ruiz-Castell M, Samouda H, Bocquet V, Fagherazzi G, Stranges S, Huiart L. Estimated visceral adiposity is associated with risk of cardiometabolic conditions in a population based study. Sci Rep. 2021;11(1):9121.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Sharma AM, Kushner RF. A proposed clinical staging system for obesity. Int J Obes. 2009;33(3):289–95.

    Article  CAS  Google Scholar 

  10. Padwal RS, Pajewski NM, Allison DB, Sharma AM. Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity. CMAJ. 2011;183(14):E1059–66.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Atlantis E, Sahebolamri M, Cheema BS, Williams K. Usefulness of the Edmonton obesity staging system for stratifying the presence and severity of weight-related health problems in clinical and community settings: a rapid review of observational studies. Obes Rev. 2020;21(11):e13120.

    Article  PubMed  Google Scholar 

  12. Schwartz MW, Woods SC, Porte D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;404(6778):661–71.

    Article  CAS  PubMed  Google Scholar 

  13. van der Klaauw AA, Farooqi IS. The hunger genes: pathways to obesity. Cell. 2015;161(1):119–32.

    Article  PubMed  Google Scholar 

  14. Sumithran P, Prendergast LA, Delbridge E, Purcell K, Shulkes A, Kriketos A, et al. Long-term persistence of hormonal adaptations to weight loss. N Engl J Med. 2011;365(17):1597–604.

    Article  CAS  PubMed  Google Scholar 

  15. Bays HE, McCarthy W, Christensen S, Seger J, Wells S, Long J, Shah NN, Primack C. Obesity algorithm slides, presented by the Obesity Medicine Association. www.obesityalgorithm.org; 2018–2019 [cited 2022 Sep 5]. https://obesitymedicine.org/obesity-algorithm-powerpoint/

  16. Huang Y, Lu Y, Huang YM, Wang M, Ling W, Sui Y, et al. Obesity in patients with COVID-19: a systematic review and meta-analysis. Metabolism. 2020;113:154378.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Yang J, Hu J, Zhu C. Obesity aggravates COVID-19: a systematic review and meta-analysis. J Med Virol. 2021;93(1):257–61.

    Article  CAS  PubMed  Google Scholar 

  18. Hendren NS, de Lemos JA, Ayers C, Das SR, Rao A, Carter S, et al. Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19. Circulation. 2021;143(2):135–44.

    Article  CAS  PubMed  Google Scholar 

  19. Rodríguez-Flores M, Goicochea-Turcott EW, Mancillas-Adame L, Garibay-Nieto N, López-Cervantes M, Rojas-Russell ME, et al. The utility of the Edmonton obesity staging system for the prediction of COVID-19 outcomes: a multi-Centre study. Int J Obes. 2022;46(3):661–8.

    Article  Google Scholar 

  20. Yu W, Rohli KE, Yang S, Jia P. Impact of obesity on COVID-19 patients. J Diabetes Complications [Internet]. 2021;35(3) https://www.proquest.com/docview/2486124588/abstract/7B59B2C2AF894005PQ/1

  21. Petrakis D, Margină D, Tsarouhas K, Tekos F, Stan M, Nikitovic D, et al. Obesity—a risk factor for increased COVID-19 prevalence, severity and lethality. Mol Med Rep. 2020 Jul;22(1):9–19.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Albashir AAD. The potential impacts of obesity on COVID-19. Clin Med (Lond). 2020;20(4):e109–13.

    Article  PubMed  Google Scholar 

  23. Sanchis-Gomar F, Lavie CJ, Mehra MR, Henry BM, Lippi G. Obesity and outcomes in COVID-19: when an epidemic and pandemic collide. Mayo Clin Proc. 2020;95(7):1445–53.

    Article  CAS  PubMed  Google Scholar 

  24. Byrd AS, Toth AT, Stanford FC. Racial disparities in obesity treatment. Curr Obes Rep. 2018;7(2):130–8.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Ogden CL, Fakhouri TH, Carroll MD, Hales CM, Fryar CD, Li X, et al. Prevalence of obesity among adults, by household income and education - United States, 2011-2014. MMWR Morb Mortal Wkly Rep. 2017;66(50):1369–73.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Simenson AJ, Corey S, Markovic N, Kinsky S. Disparities in chronic health outcomes and health Behaviors between lesbian and heterosexual adult women in Pittsburgh: a longitudinal study. J Womens Health (Larchmt). 2020;29(8):1059–67.

    Article  PubMed  Google Scholar 

  27. Cuevas AG, Chen R, Slopen N, Thurber KA, Wilson N, Economos C, et al. Assessing the role of health behaviors, socioeconomic status, and cumulative stress for racial/ethnic disparities in obesity. Obesity (Silver Spring). 2020;28(1):161–70.

    Article  PubMed  Google Scholar 

  28. Wang G, Johnson S, Gong Y, Polk S, Divall S, Radovick S, et al. Weight gain in infancy and overweight or obesity in childhood across the gestational spectrum: a prospective birth cohort study. Sci Rep. 2016;6:29867.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Cohen SA, Greaney ML, Sabik NJ. Assessment of dietary patterns, physical activity and obesity from a national survey: rural-urban health disparities in older adults. PLoS One. 2018;13(12):e0208268.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Foster BA, Weinstein K, Mojica CM, Davis MM. Parental mental health associated with child overweight and obesity, examined within rural and urban settings, stratified by income. J Rural Health. 2020;36(1):27–37.

    Article  PubMed  Google Scholar 

  31. Hernandez DC, Reesor LM, Murillo R. Food insecurity and adult overweight/obesity: gender and race/ethnic disparities. Appetite. 2017;117:373–8.

    Article  PubMed  Google Scholar 

  32. Young KL, Graff M, Fernandez-Rhodes L, North KE. Genetics of obesity in diverse populations. Curr Diab Rep. 2018;18(12):145.

    Article  PubMed  PubMed Central  Google Scholar 

  33. US Preventive Services Task Force. Behavioral weight loss interventions to prevent obesity-related morbidity and mortality in adults: US preventive services task force recommendation statement. JAMA. 2018;320(11):1163–71.

    Article  Google Scholar 

  34. Aspry KE, Van Horn L, Carson JAS, Wylie-Rosett J, Kushner RF, Lichtenstein AH, et al. Medical nutrition education, training, and competencies to advance guideline-based diet Counseling by physicians: a science advisory from the American Heart Association. Circulation. 2018;137(23):e821–41.

    Article  PubMed  Google Scholar 

  35. Kushner RF. Clinical assessment and management of adult obesity. Circulation. 2012;126(24):2870–7.

    Article  PubMed  Google Scholar 

  36. Palad CJ, Stanford FC. Use of people-first language with regard to obesity. Am J Clin Nutr. 2018;108(1):201–3.

    Article  PubMed  PubMed Central  Google Scholar 

  37. Foster GD, Wadden TA, Makris AP, Davidson D, Sanderson RS, Allison DB, et al. Primary care physicians’ attitudes about obesity and its treatment. Obes Res. 2003;11(10):1168–77.

    Article  PubMed  Google Scholar 

  38. Pool AC, Kraschnewski JL, Cover LA, Lehman EB, Stuckey HL, Hwang KO, et al. The impact of physician weight discussion on weight loss in US adults. Obes Res Clin Pract. 2014;8(2):e131–9.

    Article  PubMed  PubMed Central  Google Scholar 

  39. Joint FAO/WHO/UNU Expert Consultation. Energy and protein requirements. Geneva: World Health Organization; 1985; [Internet] https://apps.who.int/iris/bitstream/handle/10665/39527/WHO_TRS_724_(chp1-chp6).pdf?sequence=1

    Google Scholar 

  40. Anderson JW, Konz EC, Frederich RC, Wood CL. Long-term weight-loss maintenance: a meta-analysis of US studies. Am J Clin Nutr. 2001;74(5):579–84.

    Article  CAS  PubMed  Google Scholar 

  41. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, et al. American Association of Clinical Endocrinologists and American College of Endocrinology Comprehensive Clinical practice guidelines for medical care of patients with obesity. Endocr Pract. 2016;22(Suppl 3):1–203.

    Article  PubMed  Google Scholar 

  42. Piercy KL, Troiano RP, Ballard RM, Carlson SA, Fulton JE, Galuska DA, et al. The physical activity guidelines for Americans. JAMA. 2018;320(19):2020–8.

    Article  PubMed  PubMed Central  Google Scholar 

  43. Jensen MD, Ryan DH, Apovian CM, Ard JD, Comuzzie AG, Donato KA, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on practice Guidelines and The Obesity Society. Circulation. 2014;129(25 Suppl 2):S102–38.

    PubMed  Google Scholar 

  44. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK, et al. American College of Sports Medicine Position Stand. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Sports Exerc. 2009;41(2):459–71.

    Article  PubMed  Google Scholar 

  45. LeBlanc ES, Patnode CD, Webber EM, Redmond N, Rushkin M, O’Connor EA. Behavioral and pharmacotherapy weight loss interventions to prevent obesity-related morbidity and mortality in adults: updated evidence report and systematic review for the US preventive services task force. JAMA. 2018;320(11):1172–91.

    Article  PubMed  Google Scholar 

  46. Khera R, Murad MH, Chandar AK, Dulai PS, Wang Z, Prokop LJ, et al. Association of Pharmacological Treatments for obesity with weight loss and adverse events: a systematic review and meta-analysis. JAMA. 2016;315(22):2424–34.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  47. Bessesen DH, Van Gaal LF. Progress and challenges in anti-obesity pharmacotherapy. Lancet Diabetes Endocrinol. 2018;6(3):237–48.

    Article  PubMed  Google Scholar 

  48. Finkelstein EA, Kruger E. Meta- and cost-effectiveness analysis of commercial weight loss strategies. Obesity (Silver Spring). 2014;22(9):1942–51.

    Article  PubMed  Google Scholar 

  49. Cunningham JW, Wiviott SD. Modern obesity pharmacotherapy: weighing cardiovascular risk and benefit. Clin Cardiol. 2014;37(11):693–9.

    Article  PubMed  PubMed Central  Google Scholar 

  50. Mechanick JI, Apovian C, Brethauer S, Garvey WT, Joffe AM, Kim J, et al. Clinical practice guidelines for the perioperative nutrition, metabolic, and nonsurgical support of patients undergoing bariatric procedures—2019 update: cosponsored by American Association of Clinical Endocrinologists/American College of Endocrinology, the Obesity Society, American Society for Metabolic & Bariatric Surgery, Obesity Medicine Association, and American Society of Anesthesiologists—executive summary. Endocr Pract. 2019;25(12):1346–59.

    PubMed  Google Scholar 

  51. American Society for Metabolic and Bariatric Surgery. Estimate of bariatric surgery numbers, 2011-2020 [internet]. American Society for Metabolic and Bariatric Surgery; 2022 [cited 2022 Sep 10]. https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers

  52. Banerjee ES, Schroeder R. Metabolic surgery for adult obesity: common questions and answers. Am Fam Physician. 2022;105(6):9.

    Google Scholar 

  53. Coblijn UK, Verveld CJ, van Wagensveld BA, Lagarde SM. Laparoscopic Roux-en-Y gastric bypass or laparoscopic sleeve gastrectomy as revisional procedure after adjustable gastric band—a systematic review. Obes Surg. 2013;23(11):1899–914.

    Article  PubMed  Google Scholar 

  54. Cho YM. A gut feeling to cure diabetes: potential mechanisms of diabetes remission after bariatric surgery. Diabetes Metab J. 2014;38(6):406–15.

    Article  PubMed  PubMed Central  Google Scholar 

  55. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Capristo E, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-Centre, randomised controlled trial. Lancet. 2021;397(10271):293–304.

    Article  PubMed  Google Scholar 

  56. Sjöström L, Peltonen M, Jacobson P, Ahlin S, Andersson-Assarsson J, Anveden Å, et al. Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications. JAMA. 2014;311(22):2297–304.

    Article  PubMed  Google Scholar 

  57. Billeter AT, Eichel S, Scheurlen KM, Probst P, Kopf S, Müller-Stich BP. Meta-analysis of metabolic surgery versus medical treatment for macrovascular complications and mortality in patients with type 2 diabetes. Surg Obes Relat Dis. 2019;15(7):1197–210.

    Article  PubMed  Google Scholar 

  58. Khosravi-Largani M, Nojomi M, Aghili R, Otaghvar HA, Tanha K, Seyedi SHS, et al. Evaluation of all types of metabolic bariatric surgery and its consequences: a systematic review and meta-analysis. Obes Surg. 2019;29(2):651–90.

    Article  PubMed  Google Scholar 

  59. Wiggins T, Guidozzi N, Welbourn R, Ahmed AR, Markar SR. Association of bariatric surgery with all-cause mortality and incidence of obesity-related disease at a population level: a systematic review and meta-analysis. PLoS Med. 2020;17(7):e1003206.

    Article  PubMed  PubMed Central  Google Scholar 

  60. Schauer DP, Feigelson HS, Koebnick C, Caan B, Weinmann S, Leonard AC, et al. Bariatric surgery and the risk of cancer in a large multisite cohort. Ann Surg. 2019;269(1):95–101.

    Article  PubMed  Google Scholar 

  61. Persson I. Estrogens in the causation of breast, endometrial and ovarian cancers—evidence and hypotheses from epidemiological findings. J Steroid Biochem Mol Biol. 2000;74(5):357–64.

    Article  CAS  PubMed  Google Scholar 

  62. Carlsson LMS, Sjöholm K, Jacobson P, Andersson-Assarsson JC, Svensson PA, Taube M, et al. Life expectancy after bariatric surgery in the Swedish obese subjects study. N Engl J Med. 2020;383(16):1535–43.

    Article  PubMed  PubMed Central  Google Scholar 

  63. Xia Q, Campbell JA, Ahmad H, Si L, de Graaff B, Palmer AJ. Bariatric surgery is a cost-saving treatment for obesity-a comprehensive meta-analysis and updated systematic review of health economic evaluations of bariatric surgery. Obes Rev. 2020;21(1):e12932.

    Article  PubMed  Google Scholar 

  64. Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, et al. A randomized, controlled trial of 3.0 mg of liraglutide in weight management. N Engl J Med. 2015;373(1):11–22.

    Article  PubMed  Google Scholar 

  65. Wadden TA, Hollander P, Klein S, Niswender K, Woo V, Hale PM, et al. Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: the SCALE maintenance randomized study. Int J Obes. 2013;37(11):1443–51.

    Article  CAS  Google Scholar 

  66. Fidler MC, Sanchez M, Raether B, Weissman NJ, Smith SR, Shanahan WR, et al. A one-year randomized trial of lorcaserin for weight loss in obese and overweight adults: the BLOSSOM trial. J Clin Endocrinol Metab. 2011;96(10):3067–77.

    Article  CAS  PubMed  Google Scholar 

  67. Smith SR, Weissman NJ, Anderson CM, Sanchez M, Chuang E, Stubbe S, et al. Multicenter, placebo-controlled trial of lorcaserin for weight management. N Engl J Med. 2010;363(3):245–56.

    Article  CAS  PubMed  Google Scholar 

  68. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010;376(9741):595–605.

    Article  CAS  PubMed  Google Scholar 

  69. Hollander P, Gupta AK, Plodkowski R, Greenway F, Bays H, Burns C, et al. Effects of naltrexone sustained-release/bupropion sustained-release combination therapy on body weight and glycemic parameters in overweight and obese patients with type 2 diabetes. Diabetes Care. 2013;36(12):4022–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. Torgerson JS, Hauptman J, Boldrin MN, Sjöström L. XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care. 2004;27(1):155–61.

    Article  CAS  PubMed  Google Scholar 

  71. Davidson MH, Hauptman J, DiGirolamo M, Foreyt JP, Halsted CH, Heber D, et al. Weight control and risk factor reduction in obese subjects treated for 2 years with orlistat: a randomized controlled trial. JAMA. 1999;281(3):235–42.

    Article  CAS  PubMed  Google Scholar 

  72. O’Meara S, Riemsma R, Shirran L, Mather L, ter Riet G. A systematic review of the clinical effectiveness of orlistat used for the management of obesity. Obes Rev. 2004;5(1):51–68.

    Article  PubMed  Google Scholar 

  73. Li Z, Maglione M, Tu W, Mojica W, Arterburn D, Shugarman LR, et al. Meta-analysis: pharmacologic treatment of obesity. Ann Intern Med. 2005;142(7):532–46.

    Article  CAS  PubMed  Google Scholar 

  74. Allison DB, Gadde KM, Garvey WT, Peterson CA, Schwiers ML, Najarian T, et al. Controlled-release phentermine/topiramate in severely obese adults: a randomized controlled trial (EQUIP). Obesity (Silver Spring). 2012;20(2):330–42.

    Article  CAS  PubMed  Google Scholar 

  75. Gadde KM, Allison DB, Ryan DH, Peterson CA, Troupin B, Schwiers ML, et al. Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial. Lancet. 2011;377(9774):1341–52.

    Article  CAS  PubMed  Google Scholar 

  76. Garvey WT, Ryan DH, Bohannon NJV, Kushner RF, Rueger M, Dvorak RV, et al. Weight-loss therapy in type 2 diabetes: effects of phentermine and topiramate extended release. Diabetes Care. 2014;37(12):3309–16.

    Article  CAS  PubMed  Google Scholar 

  77. Garvey WT, Ryan DH, Look M, Gadde KM, Allison DB, Peterson CA, et al. Two-year sustained weight loss and metabolic benefits with controlled-release phentermine/topiramate in obese and overweight adults (SEQUEL): a randomized, placebo-controlled, phase 3 extension study. Am J Clin Nutr. 2012;95(2):297–308.

    Article  CAS  PubMed  Google Scholar 

  78. Wilding JPH, Batterham RL, Calanna S, Davies M, Van Gaal LF, Lingvay I, et al. Once-weekly Semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Family Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA

    Debbie Phipps & Margaret R. Helton

Authors
  1. Debbie Phipps
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Margaret R. Helton
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Margaret R. Helton .

Editor information

Editors and Affiliations

  1. Department of Family Medicine, University of North Carolina, CHAPEL HILL, NC, USA

    Timothy P. Daaleman

  2. Department of Family Medicine, University of North Carolina, CHAPEL HILL, NC, USA

    Margaret R. Helton

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Phipps, D., Helton, M.R. (2023). Obesity and Chronic Disease. In: Daaleman, T.P., Helton, M.R. (eds) Chronic Illness Care. Springer, Cham. https://doi.org/10.1007/978-3-031-29171-5_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-29171-5_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-29170-8

  • Online ISBN: 978-3-031-29171-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation